About
Device Access UK

Device Access UK is a dedicated medical technology reimbursement consultancy brought together under the IGES Group. Its purpose is to provide Europe-wide support for MedTech companies navigating the complex reimbursement landscapes in healthcare markets.
Device Access UK
Established in 2010, Device Access has supported over 40 successful applications for NICE approvals and more than 1000 cases for change within the NHS, prior to joining the IGES group in 2019.

Device Access has supported a wide range of international and European companies introducing high value medical technologies to the UK, effectively navigating the complex NHS reimbursement pathways through the creation and implementation of local and national market access strategies that demonstrate the technologies’ true value.

In 2017, Device Access became one of the first NICE approved facilitators for the MedTech Early Technical Assessment (META Tool®).

Device Access holds a licence from NHS Digital, which provides data on all hospital admissions and outcomes on a monthly basis, allowing them to work with companies to further understand the impact technologies may have on current patient populations.

IGES Group
The IGES group is an independent provider of research and consulting services for the life sciences industry, offering services from market data analysis, regulatory advice and health technology assessment (HTA) to analysis of clinical services.
Learn more about
Our Team
Device Access UK
MICHAEL BRANAGAN-HARRIS
CHIEF EXECUTIVE OFFICER

Michael founded Device Access UK in 2010 following more than 30 years experience in the sales and marketing of medical devices. Since 2010 he has driven the 30+ successful applications for NICE approvals and the submission of more than 1000 cases for change in the NHS.

Michael was one of the first qualified and approved NICE Meta Tool® facilitators.

DR MEHDI JAVANBAKHT
SENIOR HEALTH ECONOMIST (MSc, PhD)

Mehdi has over 13 years experience in market access and reimbursement and has produced over 50 economic evaluation models (CAE, CUA, Budget impact analyses) in different disease areas including cardiovascular, oncology, diabetes, ophthalmology, urology and otorhinolaryngology. Mehdi has also had over 80 publications accepted by high impact journals.

Mehdi works closely with NICE and is currently a senior advisor within the Research Design Service and a member of the Evidence Review Group.

DEBBIE POSTLETHWAITE
NHS MARKET ACCESS PROJECT MANAGER

Debbie has over 17 years experience in the NHS as a Service Improvement Manager. During her tenure she took a diploma in Innovations and Change Management and subsequently established, led and delivered a sustainable NHS innovation pathway from concept to commercialisation.

Debbie works closely with companies to develop business dossiers that support local and national market adoption of new technologies by the NHS.

JOWAN ATKINSON MMATH
HEALTHCARE DATA SCIENTIST

Jowan runs and maintains the SQL database that continuously contains 4 years of NHS Digital hospital episode statistics. This involves managing over 1 billion data points relating to admitted patient care, accident and emergency, critical care and outpatient tables.

Jowan works with companies to provide in-depth analysis for specific patient cohorts from the hospital episode statistics.

Contact us